Teladoc Health, Inc. (FRA:4LL)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of EUR 1.14 billion. The enterprise value is 1.41 billion.

Market Cap	1.14B
Enterprise Value	1.41B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	177.47M
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	70.23%
Float	175.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
PB Ratio	0.96
P/TBV Ratio	n/a
P/FCF Ratio	4.76
P/OCF Ratio	4.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 58.90, with an EV/FCF ratio of 5.90.

EV / Earnings	-7.39
EV / Sales	0.65
EV / EBITDA	58.90
EV / EBIT	n/a
EV / FCF	5.90

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.75.

Current Ratio	2.70
Quick Ratio	2.33
Debt / Equity	0.75
Debt / EBITDA	37.51
Debt / FCF	3.72
Interest Coverage	-8.26

Financial Efficiency

Return on equity (ROE) is -15.42% and return on invested capital (ROIC) is -4.04%.

Return on Equity (ROE)	-15.42%
Return on Assets (ROA)	-3.48%
Return on Invested Capital (ROIC)	-4.04%
Return on Capital Employed (ROCE)	-7.22%
Revenue Per Employee	425,847
Profits Per Employee	-37,661
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	19.86

Taxes

Income Tax	-22.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.95%
50-Day Moving Average	6.95
200-Day Moving Average	6.97
Relative Strength Index (RSI)	48.73
Average Volume (20 Days)	933

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, Teladoc Health had revenue of EUR 2.15 billion and -190.56 million in losses. Loss per share was -1.09.

Revenue	2.15B
Gross Profit	1.50B
Operating Income	-152.21M
Pretax Income	-213.15M
Net Income	-190.56M
EBITDA	13.78M
EBIT	-152.21M
Loss Per Share	-1.09

Balance Sheet

The company has 618.98 million in cash and 888.16 million in debt, giving a net cash position of -269.17 million.

Cash & Cash Equivalents	618.98M
Total Debt	888.16M
Net Cash	-269.17M
Net Cash Per Share	n/a
Equity (Book Value)	1.19B
Book Value Per Share	6.69
Working Capital	586.10M

Cash Flow

In the last 12 months, operating cash flow was 249.31 million and capital expenditures -10.57 million, giving a free cash flow of 238.74 million.

Operating Cash Flow	249.31M
Capital Expenditures	-10.57M
Free Cash Flow	238.74M
FCF Per Share	n/a

Margins

Gross margin is 69.80%, with operating and profit margins of -7.06% and -8.84%.

Gross Margin	69.80%
Operating Margin	-7.06%
Pretax Margin	-9.89%
Profit Margin	-8.84%
EBITDA Margin	0.64%
EBIT Margin	-7.06%
FCF Margin	11.08%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.59%
Earnings Yield	-16.78%
FCF Yield	21.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.41
Piotroski F-Score	4